IN2014MU00858A - - Google Patents

Info

Publication number
IN2014MU00858A
IN2014MU00858A IN858MU2014A IN2014MU00858A IN 2014MU00858 A IN2014MU00858 A IN 2014MU00858A IN 858MU2014 A IN858MU2014 A IN 858MU2014A IN 2014MU00858 A IN2014MU00858 A IN 2014MU00858A
Authority
IN
India
Prior art keywords
compound
formula
preparation
disclosed
Prior art date
Application number
Inventor
Vijay Prakash Chavan
Karuna Suresh Wankhede
Vikas Vithalrao Deshmukh
Satish Bhawsar
Kiran Ramchandra Patil
Ravindra Dattatraya Yeole
Prasad Keshav Deshpande
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2015/051794 priority Critical patent/WO2015136473A1/en
Priority to EP15718590.1A priority patent/EP3116875A1/en
Priority to CN201580014017.5A priority patent/CN106458896A/en
Priority to MX2016011903A priority patent/MX2016011903A/en
Priority to KR1020167026620A priority patent/KR20160132414A/en
Priority to JP2016574517A priority patent/JP2017513926A/en
Priority to US15/125,554 priority patent/US9790223B2/en
Priority to IN858MU2014 priority patent/IN2014MU00858A/en
Publication of IN2014MU00858A publication Critical patent/IN2014MU00858A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/36—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atoms of the oxyimino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

A process for preparation of compound of Formula (I) is disclosed.
IN858MU2014 2014-03-14 2015-03-12 IN2014MU00858A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
PCT/IB2015/051794 WO2015136473A1 (en) 2014-03-14 2015-03-12 A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate
EP15718590.1A EP3116875A1 (en) 2014-03-14 2015-03-12 A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate
CN201580014017.5A CN106458896A (en) 2014-03-14 2015-03-12 A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate
MX2016011903A MX2016011903A (en) 2014-03-14 2015-03-12 A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo- 1,6-diazabicyclo[3.2.1]octane-2-carboxylate.
KR1020167026620A KR20160132414A (en) 2014-03-14 2015-03-12 A process for preparation of sodium (2s, 5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate
JP2016574517A JP2017513926A (en) 2014-03-14 2015-03-12 Method for preparing sodium (2S, 5R) -6- (benzyloxy) -7-oxo-1,6-diazabicyclo [3.2.1] octane-2-carboxylate
US15/125,554 US9790223B2 (en) 2014-03-14 2015-03-12 Process for preparation of sodium (2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate
IN858MU2014 IN2014MU00858A (en) 2014-03-14 2015-03-12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN858MU2014 IN2014MU00858A (en) 2014-03-14 2015-03-12

Publications (1)

Publication Number Publication Date
IN2014MU00858A true IN2014MU00858A (en) 2015-09-25

Family

ID=53005597

Family Applications (1)

Application Number Title Priority Date Filing Date
IN858MU2014 IN2014MU00858A (en) 2014-03-14 2015-03-12

Country Status (8)

Country Link
US (1) US9790223B2 (en)
EP (1) EP3116875A1 (en)
JP (1) JP2017513926A (en)
KR (1) KR20160132414A (en)
CN (1) CN106458896A (en)
IN (1) IN2014MU00858A (en)
MX (1) MX2016011903A (en)
WO (1) WO2015136473A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011505341A (en) 2007-11-21 2011-02-24 デコード ジェネティクス イーエイチエフ Biaryl PDE4 inhibitors to treat inflammatory, cardiovascular and CNS disorders
US20120053350A1 (en) * 2009-04-30 2012-03-01 Ian Mangion Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
US8772490B2 (en) * 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
JP6023800B2 (en) 2011-06-17 2016-11-09 アストラゼネカ アクチボラグ Process for producing a heterocyclic compound containing trans-7-oxo-6- (sulfooxy) -1,6-diazabicyclo [3,2,1] octane-2-carboxamide and a salt thereof
CA2869051A1 (en) * 2012-03-30 2013-10-03 Cubist Pharmaceuticals, Inc. Isoxazole .beta.-lactamase inhibitors
AU2013380572B2 (en) * 2013-03-08 2016-07-21 Wockhardt Limited Sodium salt of (2S, 5R)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation
CA2926773A1 (en) 2013-10-11 2015-04-16 Wockhardt Limited Nitrogen containing compounds and their use

Also Published As

Publication number Publication date
KR20160132414A (en) 2016-11-18
US20170008892A1 (en) 2017-01-12
WO2015136473A1 (en) 2015-09-17
US9790223B2 (en) 2017-10-17
CN106458896A (en) 2017-02-22
JP2017513926A (en) 2017-06-01
EP3116875A1 (en) 2017-01-18
MX2016011903A (en) 2016-12-05

Similar Documents

Publication Publication Date Title
MX2020001278A (en) Synthesis of polycyclic-carbamoylpyridone compounds.
NZ726356A (en) Processes for preparing antiviral compounds
GR20140100479A (en) Synthesis of liraglutide
AU2016277367A8 (en) Aryl sulfonohydrazides
IN2014CH00247A (en)
MX369501B (en) Process for the preparation of 5-fluoro-1h-pyrazoles starting from hexafluoropropene.
MX2016010973A (en) Aminocarbonylcarbamate compounds.
MX2016015543A (en) Process for the preparation of 5-fluoro-1h-pyrazoles starting from hexafluoropropene.
MA39843A (en) Pyridine-2-amides useful as cb2 agonists
PH12018550165A1 (en) An improved process for the preparation of butorphanol tartrate
MX2015013589A (en) Process and intermediates for the preparation of pregabalin.
MX2019004024A (en) Method for producing cyclopropyl-substituted acetophenones.
IN2014MU01192A (en)
IN2014MU00195A (en)
MX2016015624A (en) Process for preparing thiazole derivatives.
MX2016015623A (en) Process for preparing dihydroisoxazole derivatives.
IN2014MU00194A (en)
IN2014MU01196A (en)
MX2016016398A (en) Preparation of piperidine-4-carbothioamide.
MX2017002609A (en) Improved process for the preparation of lacosamide and its novel intermediate.
IN2014CH00444A (en)
CL2016002925A1 (en) Improved procedure to prepare substituted crotonic acids
IN2014MU00858A (en)
IN2014MU01195A (en)
IN2014MU00072A (en)